ASX 100

This $60m ASX-listed biotech, with a cutting-edge pipeline of transformative therapies, stands at a key inflection point for value creation.

Lithium minerals markets have been dynamic over the past few weeks, with prices staging a modest rally. We check up on the key developments.

Generative AI assistants are rapidly improving. We investigate how one assistant can help investors understand complicated investing jargon.

Our guest for this Ep is Jennifer Westacott AO & what a conversation it is – an inspiring story of one of Australia’s leading women.

High quality companies have been repeat M&A targets of late. This wire details the material demand for high quality assets across sectors

You'll find out in this episode of Buy Hold Sell.

Milford's Dynamic Small Companies Fund has delivered investors 5.35% of outperformance p.a. since 2019. Here are the stocks they're backing.

With the S&P/ASX 200 hitting new highs, we ask “What’s in store for 2025?” How much higher can Aussie shares go!?

Plus, why investors will have to question whether Donald Trump's pro-growth policies are really pro-inflation ones.

In this episode, David Keelan from Ellerston and Andrew Peros from Ausbil analyse some of the ASX's top small caps.

Its model portfolio may have underperformed the benchmark by 2.25%, but Morgan Stanley's sell-side team are holding firm to their call.

Hear Michael, Co-Founder of Collins St AM, explain how hands-on research & real-world insights uncover hidden value in Aussie equities.

The investment world has become hyper-concentrated, so where can investors turn for uncorrelated returns?

Firetrail's Australian Small Companies Fund has shot the lights out over the past 12 months. Here, they reveal the stocks they are backing.

Perpetual's Anthony Aboud argues shorting decisions should be more than valuation based and shares the opportunities he's watching.

“Make America great again”. Not Europe, not Australia, and certainly not China. Which ASX stocks stand to benefit the most from Trump’s win?

Jun Bei Liu from Tribeca and David Moberley from ClearLIfe Capital analyse five stocks that could weather a coming downturn.

As emotions run high, anchoring on rational fundamentals is tougher, but probably more important than ever.

In episode four of our 'Value Added Insights' series, I review the recent bank earnings season, shares my outlook for the sector in 2025, and discuss why ANZ stands...

While everyone's attention is focused on Mineral Resources and WiseTech, there are other companies on the ASX that are flashing red.

Bitcoin prices are surging, gold prices (after surging all year) appear to be faltering. So, which is the better bet for your portfolio now?

An exciting business, with high conviction in its future prospects.

Discover the growing landscape of listed alternative funds in Australia, exploring their role, different types, and associated risks.

If you love a stock pick, long or short, then this episode is for you. Don't miss it.